In Brief
Two Ab-producing enzymes associated with Alzheimer's disease have different subcellular locations and generate distinct Ab pools. Disease-associated mutations in these enzymes strongly increase intracellular longer Ab, suggesting pathological significance for this pool in the disease process.
INTRODUCTION
g-Secretases constitute a family of biologically and pathologically relevant intramembrane-cleaving proteases (i-Clips) (Jurisch-Yaksi et al., 2013; Wolfe, 2009) . They consist of four subunits and are structurally very different from other i-Clips, such as the rhomboids (Freeman, 2014) as well as signal peptide peptidases (SPPs) and SPP-like proteases (SPPLs) (Voss et al., 2013) , which are monomeric or dimeric proteins. The catalytic activity of the complex is provided by the presenilin (PSEN)1 or PSEN2 subunit, while three additional subunits, APH1A or B/C, nicastrin (NCSTN), and PEN-2 are needed to build a functional enzyme (De Strooper and Annaert, 2010; Edbauer et al., 2003; Takasugi et al., 2003) . Thus, and disregarding alternative splicing of PSEN and APH1 subunits, at least four distinct g-secretase complexes can coexist in the same cell (De Strooper and Annaert, 2010) . To date, it is unclear why cells express so many different g-secretases, since overexpression studies suggest that the different complexes can cleave the same substrates, and mutations in both PSEN genes can cause Alzheimer's disease (AD). On the other hand, murine knockouts (KOs) of different subunits show major phenotypical differences, suggesting biologically diverse functions (Jurisch-Yaksi et al., 2013; Serneels et al., 2005) . For instance, PSEN1 or APH1A KO mice show severe embryonic phenotypes due to deficient Notch signaling, while PSEN2 or APH1B/C KO mice display a normal lifespan (Serneels et al., 2005) . Biochemical evidence also suggests that the four different g-secretase complexes process the amyloid precursor protein (APP) differently, generating shorter or longer Ab peptides depending on the subunit composition (Acx et al., 2014) .
Other i-Clips make use of the compartmentalization of the cell to control cleavage of their various substrates (Freeman, 2014; Golde et al., 2009; Krawitz et al., 2005) . However, it is remarkable how little is known about the subcellular compartmentalization of g-secretase complexes (De Strooper and Annaert, 2010) . Here, we used a variety of approaches to establish that two major g-secretase classes, comprising PSEN1 and PSEN2 as alternative subunits, have very different subcellular locations. We identify a motif in PSEN2 that restricts its location to late endosomes/ lysosomes (LE/LYS) and interacts specifically and in a phosphorylation-dependent manner with the trans-Golgi network (TGN)/ endosomal adaptor complex protein (AP) complex AP-1 (Bonifacino, 2014) . This more restricted localization of PSEN2 is conserved in a wide range of cell lines, in primary neurons, and in brain. PSEN1, instead, is more broadly distributed in the cell, including the plasma membrane. This distinct distribution explains the differential preference for substrates of PSEN1 versus PSEN2 complexes. In addition, we find that PSEN2 produces a distinct intracellular pool of Ab that has been inferred to be pathological relevant but whose origin was never precisely determined (Friedrich et al., 2010; Gouras et al., 2010; Pensalfini et al., 2014) . Moreover, familial AD (FAD) mutations in PSEN2 strongly increase intracellular aggregation-prone Ab42 production, and some FAD-PSEN1 mutations phenocopy FAD-PSEN2 with respect to localization, substrate specificity, and intracellular Ab42/40 ratio.
RESULTS

PSEN2/g-Secretase Is Restricted to LE/LYS
To analyze the intracellular distribution of PSEN1 and PSEN2, we fractionated a postnuclear supernatant of wild-type (WT) mouse embryonic fibroblasts (MEFs) by discontinuous sucrose/D 2 O gradient centrifugation. PSEN1 immunoreactivity broadly distributed in all fractions, whereas PSEN2 displayed a strong enrichment in fractions containing the LE/LYS markers Rab7 and Cathepsin D. The different fractions all contained active g-secretase, as demonstrated by de novo Ab production using an in vitro g-secretase assay ( Figures 1A and 1A' ). Magnetic isolation of LE/LYS using superparamagnetic iron oxide nanoparticles (SPIONs) confirmed that PSEN2, but not PSEN1, coenriched with Rab7 and LAMP1 ( Figure 1B ). Finally, cell-surface biotinylation of WT MEFs revealed a significant level of PSEN1 (9% ± 2.8; n = 4) at the cell surface, whereas PSEN2 was barely detected (1% ± 0.8; n = 3) ( Figures 1C and 1C' ). Similar results were obtained with several independent cell lines, underscoring a broad conservation of the distinct distribution of PSEN1 and PSEN2 ( Figures 1D and 1E) .
We further confirmed the restricted localization of PSEN2 using confocal microscopy. The higher expression of PSEN2 in HEK293, MNT-1, and A549 cells ( Figure S1A ) allowed us to demonstrate the enrichment of endogenous PSEN2 in LAMP1-positive LE/LYS ( Figure 1F ). Also, in murine primary hippocampal neurons ( Figure 1G ) and brain tissue ( Figure 1H ), endogenous PSEN2 strongly co-localized with LAMP1, particularly in somatodendritic compartments. Because of the unavailability of antibodies that detect low levels of endogenous PSEN1 and in order to generate a cell model to study transport regulation, we engineered N-terminally fluorescent protein (GFP or TagRFP [red fluorescent protein])-tagged PSEN1 and PSEN2 constructs and retrovirally expressed them in PSEN1 and PSEN2 singleand double-KO (dKO) MEFs. We selected cell lines that expressed physiological (i.e., stoichiometric to other g-secretase subunits) levels of PSENs, as demonstrated by endoproteolysis of GFP-PSEN, mature N-glycosylation of NCSTN, PEN-2 stabilization, and processing of APP-C-terminal fragment (CTF), the direct substrate of g-secretase ( Figure 1I ). Of note, NCSTN was more abundant (1.7-fold) at the cell surface in PSEN1-versus PSEN2-rescued dKO MEFs ( Figures 1J and 1J' ), confirming the presence of PSEN1 complexes at the cell surface. GFP-PSEN2 was, as expected, mainly restricted to LAMP1-positive LE/LYS compartments ( Figure 1K ). Similar patterns were observed when PSEN1 and PSEN2 were rescued in single-KO MEFs. GFP-PSEN1 co-localized with the endoplasmic reticulum (ER) marker BIP and with transferrin receptor at the cell surface ( Figure S1B ), and GFP-PSEN2 co-localized with LAMP1 (Figure S1C) . We also co-expressed both PSENs in dKO MEFs with identical results, implying that the overall localization of one PSEN is not influenced by the other (Figures S1B-S1D) . Moreover, analysis of isolated plasma membrane sheets of De novo Ab production measured using a cell-free assay. (A') Quantification of the enrichments from (A) for PSEN1 (blue), PSEN2 (orange), and g-secretase activity (Ab, red); data indicate mean ± SEM; n = 2 for PSENs, n = 4 for Ab. F, fraction. (B-C') Quantitative western blot of LE/LYS isolated using SPIONs (B) and cell-surface-biotinylated PSENs and nicastrin (NCT) (B-C'). Data indicate mean ± SEM; n = 3. (D and E) Same as in (B and C) for the indicated cell lines (mean ± SEM; n = 2-4). (F) Double immunostaining of endogenous PSEN2 and LAMP1 confirming LE/LYS enrichment for PSEN2 in indicated cell lines. Scale bars, 10 mm. (G and H) Endogenous PSEN2 co-localizes with LAMP1 in murine primary hippocampal neurons (days in vitro [DIV]7, G) and in brain cerebral cortex area (P10, H). Inset in (G): zoomed area. Scale bar, 10 mm. (H) Merge 2 (subicular area) and Merge 3: respective zoomed areas of the square in Merge 1 and Merge 2. Scale bars, 200 mm for Merge 1 and 10 mm for Merge 2 and Merge 3. (I) Western blot analysis of PSEN dKO MEFs and dKO MEFs stably rescued with GFP-PSEN1 or GFP-PSEN2 demonstrates restored g-secretase assembly and activity. (J and J') Quantitative western blot of cell-surface-biotinylated GFP-PSEN1 and -PSEN2 shows more GFP-PSEN1 at the cell surface (mean ± SEM; n = 4). (K) Co-localization of GFP-PSEN1 (top) and GFP-PSEN2 (bottom) with endogenous LAMP1. Insets and right panel: zoomed areas. Scale bars 10 mm. (L) Primary hippocampal neurons (DIV7) expressing GFP-PSEN1 (green, top), or GFP-PSEN2 (green, bottom) labeled with LysoTracker red (50 nM). Inset: GFP-PSEN2 co-localizes with LysoTracker. Scale bars, 10 mm. See also Figure S1 .
GFP-PSEN1-and TagRFP-PSEN2-rescued dKO MEF lines confirmed the higher level of PSEN1 and the sparse presence of PSEN2 at the cell surface ( Figure S1E ). GFP-PSEN1 was, as well, more abundant in cell-surface-biotinylated fractions, while GFP-PSEN2 co-purified with LAMP1 in LE/LYS isolates ( Figures  1J, 1J' , and S1F). Finally, when expressed in primary hippocampal neurons, GFP-PSEN2, but not GFP-PSEN1, localized to LysoTracker-positive compartments ( Figure 1L ), confirming that the tagged PSENs behave as their endogenous counterparts also in neurons.
The N Terminus of PSEN2 Contains a Unique Acidic-Dileucine Sorting Motif We hypothesized that the restricted localization of PSEN2 complexes might be the consequence of a specific sorting motif. Transmembrane domains (TMDs) are highly conserved between PSEN1 and PSEN2, while the cytosolic N terminus and loop between TMD6 and TMD7 are highly divergent. We swapped these domains between the PSENs ( Figure 2A ) and stably expressed the hybrid proteins in dKO MEFs. We found that all hybrids rescued g-secretase maturation and activity ( Figure 2B ). However, whereas the cytosolic loop swap (hybrids 2 and 3) did not alter PSEN1 localization, the exchange of its N terminus with the one from PSEN2 (hybrid 4) was sufficient to direct PSEN1 to LE/LYS, as shown by co-localization with LAMP1 (Figures 2C and 2C') . Conversely, replacing the N terminus of PSEN2 by that of PSEN1 (hybrid 5) resulted in a WT PSEN1-like distribution. Thus, crucial sorting information is located within amino acids 1-76 of PSEN2.
Inspection of the PSEN2 N-terminal segment revealed a highly conserved E 16 RTSLM 21 sequence ( Figure 3A) , which fits the acidic-dileucine motif [D/E]xxxL[L/I/M] present in other proteins that are transported to LE/LYS (Traub and Bonifacino, 2013) . This motif is known to bind to the heterotetrameric AP complexes AP-1, AP-2, and AP-3, which sort cargo at different stages of the endomembrane system. To determine whether the PSEN2 motif binds to these complexes, we first used a yeast three-hybrid (Y3H) assay (Mattera et al., 2011) (Figures 3B and 3C) . We found that the PSEN2 N terminus interacted with the AP-1 g1-s1 hemicomplex but not the AP-2 a-s2 and AP-3 d-s3 hemicomplexes ( Figure 3C ). This interaction was lost when essential amino acids in the PSEN2 motif (Glu 16 , Leu 20 -Met 21 , or combinations of them) were mutated to Ala ( Figures 3C and 3D) . Interestingly, interaction with the AP-2 hemicomplex was detected only when Met 21 was substituted by Leu ( Figure S2A ), indicating that the C-terminal LM configuration of the motif is responsible for its selective binding to AP-1.
Next, we performed pull-down experiments from rat brain extracts using glutathione S-transferase (GST) fused to the PSEN N-termini and again observed selective co-isolation of endogenous AP-1 only with GST-N 1-86 PSEN2, as detected by immunoblotting for the g subunit (AP1G1) ( Figure 3E ). This interaction was not seen when critical residues in the PSEN2 motif were mutated to Ala ( Figure 3F, top) . Finally, co-immunoprecipitation from extracts of cell lines expressing higher endogenous PSEN2 levels ( Figure S1A ), also confirmed interaction with AP-1 ( Figure S2B ). Figure 3A ) has been shown to undergo phosphorylation in vivo (Walter et al., 1996) . We mutated this residue, and also two other conserved proximal serines (Ser 7 and Ser 9 ) in GST-N 1-86 PSEN2, to a non-phosphorylatable Ala or a phosphomimetic Asp. Mutation of Ser 19 to Asp (S 19 D) but not Ala (S 19 A) abrogated AP-1 interaction in Y3H ( Figure 3D ) and GST pull-down assays ( Figure 3F , lower panel), suggesting that the interaction of PSEN2 with AP-1 is regulated by Ser 19 phosphorylation. In contrast, the other mutations did not affect interaction, again confirming the specificity of the effects of the Ser 19 mutation. Then, we tested the physiological importance of these interactions in intact dKO cells stably expressing GFP-PSEN2 WT or the AxxxAA, S 19 A, and S 19 D mutants. All constructs were expressed at physiological levels, as shown by the restoration of g-secretase assembly and activity ( Figure S2C ). In line with Y3H and GST pull-down experiments, co-immunoprecipitation analysis showed that AP-1 binds to PSEN2 WT and PSEN2-S 19 A, but not to PSEN2-AxxxAA and only weakly to PSEN2-S 19 D ( Figures 3G and 3G' ). Note that, under these conditions, significantly more endogenous AP-1 bound to PSEN2-S 19 A, indicating a stronger interaction.
The
canonical [D/E]xxxL[L/I/M] motif binds to AP-1 through interaction of the C-terminal L[L/I/M] residues with s1 (AP1S1)
and through the N-terminal D/E residues with g (AP1G1), as shown by structural and biochemical analysis (Jia et al., 2014; Kelly et al., 2008; Mattera et al., 2011) . Based on the available crystal structure of AP-1 (Jia et al., 2014) , we calculated the interaction energies (DDG values in kcal , mol À1 ) for the different mutant versus WT PSEN2 motifs using the FoldX force field (Figure 3I) . We obtained high positive DDG values when substituting Leu 20 -Met 21 and Glu 16 residues to Ala, consistent with their critical importance for the binding of the PSEN2 motif to the groove of the s1 and g1 subunits, respectively ( Figure 3H ). In this analysis, the S 19 D mutation or the addition of a phosphate to Ser 19 (ERTpSLM) also disfavored the interaction by more than 1.5 kcal , mol À1 ( Figure 3I ) as a result of non-optimal hydrogen bonding and electrostatic interactions with the surrounding residues in the s1 subunit. Several mutations at this position are predicted to be detrimental for the interaction, in particularand next to Asp-Glu, which is, as well, phosphomimetic, and the structurally related Asn (D, E, and N in Figure S2D ). Although casein kinase 1 (CK1) was previously suggested to phosphorylate Ser 19 (Walter et al., 1996) , this was not confirmed by a kinase-substrate predicting algorithm (http://scansite3.mit. edu). Instead, Aurora A appeared to be a more likely candidate to phosphorylate Ser 19 , while Ser 9 was predicted to be a casein kinase 2 (CK2) site. To explore this prediction, we performed in vitro kinase assays using recombinant kinases and either GST or GST-N 1-86 PSEN2 as substrates ( Figure 3J ). These data conclusively demonstrated that Ser 19 is preferentially phosphorylated by Aurora A and also confirmed the phosphorylation of Ser 7 /Ser 9 by CK2. The direct phosphorylation of Ser 19 by Aurora A was furthermore confirmed by tandem mass spectrometry (MS/MS) analysis of in-vitro-phosphorylated, trypsin-digested GST-N 1-86 PSEN2 ( Figure S2E ). Taken together, these data strongly support the phosphorylation-regulated interaction of PSEN2 with AP-1.
The E 16 RTSLM 21 Motif Regulates the Targeting of PSEN2 to LE/LYS Next, we assessed the effect of different E 16 RTSLM 21 mutations on the localization of GFP-PSEN2 to LE/LYS. The phosphomimetic GFP-PSEN2-S 19 D mutant co-localized less well with LAMP1 than did WT PSEN-2 ( Figures 4A and 4A' ). The sorting mutant GFP-PSEN2-AxxxAA displayed an even lower co-localization with LAMP1 and exhibited a broad distribution resembling that of GFP-PSEN1 ( Figure 1K ). In accordance, using cell-surface biotinylation, GFP-PSEN2-AxxxAA was, like GFP-PSEN1 ( Figure 1J '), more abundantly localized at the plasma membrane (Figures 4B and 4B'). Interestingly, in primary hippocampal neurons, AP-1 regulates sorting of receptors, such as the transferrin receptor, to the somatodendritic domain (Farías et al., 2012) . Using specific axonal and dendritic markers, we measured the polarity index of PSEN2 in neurons. This clearly showed that GFP-PSEN2 is exclusively present in the somatodendritic compartment, while GFP-PSEN1 localizes to both axons and dendrites ( Figures 4C and 4C') . Interestingly, GFP-PSEN2-AxxxAA exhibited a non-polarized distribution, indeed suggesting that AP-1 sorts PSEN2 to somatodendritic LE/LYS in neurons ( Figure 4C' ). Altogether, these results further validate the role of AP-1 in the sorting and localization of PSEN2.
Intriguingly, the non-phosphorylatable GFP-PSEN2-S 19 A, accumulated not only in LE/LYS but also prominently in the TGN, as shown by the co-localization with TGN46 ( Figure 4D ) and AP-1 ( Figure 4E ). Occasionally, co-localization could be observed over long tubules emanating from the TGN ( Figure 4E , inset). To further support the TGN localization of GFP-PSEN2-S 19 A, we co-expressed LAMP1-mCherry and correlated two-color structured illumination microscopy imaging with electron microscopy (SIM-CLEM). GFP-PSEN2 WT is mainly localized to the limiting membrane of LAMP1-positive organelles that could be identified at the ultrastructural level as LE/multivesicular bodies (MVBs) and LYS ( Figures 4F and 4F' ). In contrast, GFP-PSEN2-S 19 A localized additionally to a juxtanuclear area ( Figure 4G ) that, at the electron microscopy (EM) level, associated with tubular structures and vesicles of the TGN, as evidenced by the presence of clathrin coats and their close vicinity to Golgi stacks (<500 nm; Peden et al., 2004 ) ( Figure 4G '; Movies S1 and S2, using two-color SIM-CLEM with LAMP1-mCherry and MitoTracker, respectively).
The aforementioned results suggest that AP-1 plays a role in sorting PSEN2 from the TGN to the LE/LYS, although this role may not necessarily involve direct delivery but, rather, routing via endosomal compartments (Braulke and Bonifacino, 2009; Saftig and Klumperman, 2009 ). To test the involvement of early endosomes (EEs) in this routing, we overexpressed Rab5Q79L, a guanosine-triphosphate (GTP)-locked mutant blocking transport from EEs. GFP-PSEN2, but not GFP-PSEN1, readily accumulated in enlarged endosomes under these conditions ( Figure S3A ). Moreover, overexpression of Rab11, which causes cargo to accumulate in recycling endosomes, resulted in the trapping of GFP-PSEN1, but not GFP-PSEN2, in this compartment ( Figure S3B ). Under the same conditions, GFP-PSEN2 AxxxAA, but not the non-phosphorylatable S 19 A mutant, co-localized with overexpressed Rab11 ( Figure S3B ). Overall, these data indicate that the interaction with AP-1 directs PSEN2, via EEs, to LE/LYS, while PSEN1 traffics through the Rab11-recycling compartment, likely en route to the cell surface.
The Subcellular Localization of PSENs Affects Substrate Specificity We wondered whether the different subcellular localizations of PSEN1/-and PSEN2/g-secretases could provide a basis for substrate specificity. Among candidate substrates that localize to LE/LYS, two proteins involved in the biogenesis of melanosomes (a type of LYS-related organelle), tyrosinase-related protein (TRP1) and premelanosome protein (PMEL) (Wang et al., 2006; Watt et al., 2013) . Indeed, confocal microscopy showed localization of endogenous PSEN2 to LAMP1-positive LE/LYS in MNT-1, a human melanocyte cell line (Raposo and Marks, 2007) (57% overlap; Figure 1F ), while exogenous PMEL co-localized with GFP-PSEN2 in rescued dKO MEFs ( Figure S4A ), conclusively demonstrating that substrate and enzyme are present within the same organelles.
We next used small interfering RNA (siRNA) to silence PSEN1 or PSEN2 expression in MNT-1 cells. Knockdown of PSENs did not affect the overall maturation of PMEL or TRP1 ( Figure S4B ). However, the g-secretase cleavage products PMEL-CTF and TRP1-CTF accumulated dramatically in PSEN2 knockdown MNT-1 cells, while only a moderate effect was seen in PSEN1 knockdown cells (Figures 5A and 5A') . Similar results were (G and G') Co-immunoprecipitation of CHAPSO extracts from dKO MEFs (control) and rescued cells using anti-GFP antibody. Western blot (G), quantified in (G'), with anti-AP-1-g1 shows increased binding to GFP-PSEN2-S 19 A compared to PSEN2 WT (mean ± SEM; n = 3). *p < 0.05; ***p < 0.001. (H) Surface representation of the s1 subunit (blue) and g1subunit (green) of AP-1 hemicomplex with the VCDERTSLMS peptide from PSEN2 (gray) in the binding groove of the s1 subunit. Glu (red) and Leu/Met (purple) interact with the g1 and s1 subunit, respectively. The phospho-group on Ser 19 which disfavors interaction, is marked in yellow and red. (I) Theoretical effect of mutations on the interaction energy between the ''CDERTSLMS'' motif and the AP-1 hemicomplex, calculated using the FoldX force field. All mutations, except S 19 A, strongly destabilize interaction; high (>1) positive DDG (kcal , mol À1 ).
(J) In vitro kinase assays using purified GST-PSEN2 WT and mutants as substrates incubated with CKII, CKI, or Aurora A. Top: autoradiograph of phosphorylated GST-fusion proteins. Note very low labeling of fusion proteins by CK1 compared to control (Casein). Middle: colloidal staining shows equal loading. Bottom: quantification of 32 P incorporation in GST-fusion proteins as a ratio to colloidal gold staining (mean ± SEM; n = 3). **p < 0.01, ***p < 0.001.
See also Figure S2 .
obtained with single PSEN1-or PSEN2-KO MNT-1 cells generated by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) genome editing ( Figure 5C ). Of note, the KO cell lines showed accumulation of APP-CTF, demonstrating that APP can be processed by either one of the PSENs ( Figure S4C ). The physiological relevance of PSEN2-catalyzed cleavage was evident from further EM analysis showing that the maturation of melanosomes was impaired in PSEN2 knockdown and knockout cells ( Figures 5B, 5D , and 5D'), along with a sharp decrease of stage III and IV mature melanosomes and accumulation of stage II immature melanosomes (Watt et al., 2013) . Finally, melanosomes in retinal pigment epithelium (RPE) of Psen2 À/À mice appeared significantly rounder, less numerous, and surrounded by an enlarged limiting membrane ( Figure S4D ). These data indicated that PSEN2-selective substrate processing is required for proper melanosome maturation, both in cultured cells and in mice. Next, we analyzed the distribution of more ubiquitously expressed substrates such as APP, N-cadherin, and Notch. APP and Notch are distributed in intracellular compartments and are also present at the cell surface (Perez et al., 1999; Sannerud and Annaert, 2009; Tagami et al., 2008) , while N-cadherin mainly resides at the cell surface (De Strooper and Annaert, 2010) . We isolated crude membrane fractions in the absence of detergent, reasoning that, under these conditions, the different g-secretases would only cleave substrates that are in the same membrane compartment in vitro. We analyzed membranes isolated from cells expressing only GFP-PSEN1 or -PSEN2, or from the different cell lines expressing sorting mutants. Cell-surface-expressed N-cadherin-CTF was less efficiently cleaved by PSEN2/g-secretase than by PSEN1/g-secretase (Figures 5E and 5E'). Swapping of the sorting motif between PSEN1 and PSEN2 (hybrids 4 and 5, respectively; Figure 2A ) largely reversed this preference. Expression of the other sorting mutants confirmed this observation. GFP-PSEN2-S 19 A, which is restricted to the TGN and LE/LYS, failed to process N-cadherin, while GFP-PSEN2-AxxxAA showed increased N-cadherin cleavage (Figures 5F and 5F'), reminiscent of WT PSEN1. APP-CTF was processed to the APP-intracellular-domain (AICD) fragment to similar extents by both g-secretase complexes, as expected. Also, the PSEN2 and PSEN1 sorting mutants did not affect significantly this cleavage, in agreement with the broad and rather uniform distribution of APP in various cellular membranes (Figures 5E -5F'). PSEN1 and PSEN2 localization did not affect endogenous Notch ICD (NICD) production from its precursor substrate NEXT (following ectodomain shedding of mature Notch1 by the ADAM family of metalloproteases) in conditions of naive or delta-ligand-induced Notch signaling ( Figures 5G  and 5G'; Figures S4E and S4E') . Thus, regulated intramembrane proteolysis of Notch1 is not confined to the cell surface. Instead, and following ectodomain shedding, NEXT is either cleaved at the cell surface or is internalized and sorted to LE/MVBs for further processing to NICD as demonstrated previously (Maes et al., 2014; Tagami et al., 2008) . As opposed to APP, however, expression of PSEN2-S 19 A, which is even more depleted from the cell surface and restricted to the LE/LYS and TGN, decreased NICD production, while the S 19 D mutation displayed more processing ( Figures 5G' and S4E' ). These observations suggest that Notch1 processing is affected by subtle changes in PSEN2 localization. This might be of relevance to cancer-related Notch mutations and/or the observed high variability in PSEN2 expression levels in different cancer cell lines ( Figure S1A ).
When we analyzed Ab production in intact cells transduced with APP-CTF (APP-C99-3xFLAG), the direct substrate of g-secretase, we confirmed that PSEN2-expressing cells secrete less Ab40 and Ab42 compared to PSEN1-expressing cells ( Figures  5H-5J) (Bentahir et al., 2006) . Unexpectedly, this was accompanied by a significant increase in intracellular Ab (Figures 5H and 5I: total Ab; Figure 5J : Ab40 and Ab42). In addition, for both PSEN1-and PSEN2-expressing cells, the intracellular ratios of long to short Ab tended to be higher than those of the secreted peptides ( Figure 5K ), indicating that, even in cells expressing WT PSENs, relatively more aggregation-prone Ab42 remains intracellularly or in the LE/LYS. Increases in intracellular Ab and decreases in secreted Ab peptides were even more pronounced with the PSEN2-S 19 A but not the S 19 D mutant, indicating that PSEN2-generated Ab in LE/LYS does not get secreted efficiently. In agreement, the AxxxAA mutant, which fails to be delivered to LE/LYS, produced low intracellular and higher extracellular amounts of Ab peptides reminiscent of PSEN1 processing ( Figures 5J and J' ). Similar results for total Ab were obtained in cells transduced with the APPswedish mutant ( Figure S4F ). Thus, our data demonstrate that the differential localization of PSEN1/-and PSEN2/g-secretases results in differential processing of N-cadherin and Notch1 and also has important implications for the processing of APP toward intracellular Ab. in (F' and G') . See also Figure S3 and Movies S1 and S2.
FAD Mutations in PSEN1 and PSEN2 Generate High Intracellular Ab 42/40 Ratios
The >180 FAD mutations reported for PSEN1 are in great contrast to the limited number of FAD-PSEN2 mutations. So far, only 29 have been identified, 13 of which are pathogenic (Canevelli et al., 2014) (http://www.molgen.vib-ua.be/ ADMutations; Cruts et al., 2012) . No clear reason for this discrepancy currently exists. Our findings break new ground for studying the effect of FAD mutations on the localization and production of intracellular Ab peptides. We introduced four FAD mutations-T122P, N141I, M239V, and M239I-into GFP-PSEN2 and expressed these constructs stably in PSEN dKO MEFs ( Figure S5A ). FAD mutations did not affect the subcellular localization of PSEN2, as these constructs displayed identical co-localizations with LAMP1 ( Figures 6A and 6B ) but differently affected substrate processing. Both the PSEN2 T122P and the N141I mutations strongly decreased N-cadherin-and Notch-CTF processing but had no effect on AICD production ( Figure 6C ). The opposite effects were seen for the related FAD mutations M239V and M239I, which mainly affected AICD production while sparing other substrates. All FAD mutations significantly decreased extracellular Ab, which is caused by a major drop in Ab40 (Figures 6D and 6E ). While this is compensated by increased Ab42, what was unanticipated, however, was that this compensation is much more pronounced in the intracellular pool, resulting in a dramatic rise in Ab42/40 ratios, with FAD-N141I being the most extreme (Ab42/40 >50-fold compared to WT PSEN2) ( Figure 6F ). Hence, the FAD mutations in PSEN2 suggest that the effects on carboxypeptidase-like processing of g-secretase are more strongly enhanced in the LE/LYS compartments, indicating that the localization modulates this important pathogenic aspect of PSEN function.
Next, we wondered whether FAD-PSEN1 mutations might affect localization and intracellular Ab generation too. We selected five common mutations and generated stably rescued dKO MEFs ( Figure S5B ). To our surprise, two out of five mutations (L166P and G384A) caused re-localization of GFP-PSEN1 to LAMP1-positive organelles indistinguishable from PSEN2 ( Figures 6G and 6H ). Similar to PSEN2, they failed to process N-cadherin-CTF to ICD while affecting other substrates to a lesser extent. Interestingly, several FAD mutations decreased NICD production but did not affect AICD or N-cadherin ICD ( Figure 6I ), underscoring that individual mutations affect major substrates differently, which could contribute to pathology.
Again, the loss of Ab40 concomitant with increases in Ab42 was strongly observed in the mutations that affected the localization of PSEN1-and this, most noticeably, in the intracellular pool-resulting here also in the highest Ab42/40 ratios ( Figures  6K and 6L) . In conclusion, we demonstrated that some FAD-PSEN1 mutations additionally act strongly on the localization of g-secretase, which apparently significantly promotes the generation of intracellular long Ab42. We also obtained fibroblasts from one FAD-PSEN2 N141I patient. Remarkably, quantitative effects of total Ab were less pronounced, in line with the fact that three normal psen alleles are present ( Figures S5C and  S5D ). However high intracellular Ab42 was observed, suggesting that the pathogenic allele acts as expected. Thus, in these fibroblasts, we found a selective high intracellular Ab42, which is not observed in control fibroblasts and independent FAD-PSEN1 patient fibroblast lines and correlates with the more restricted LE/LYS localization of PSEN2. Importantly, the effect of such mutation is unlikely to become clear from studies limited to extracellular Ab, as the main effects occur in the intracellular compartment.
DISCUSSION
Here, we demonstrate that PSEN2/g-secretase is mainly restricted to a specific subcellular compartment, i.e., LE/LYS, in contrast to PSEN1/g-secretase, which is broadly distributed in the cell, including plasma membrane. This differential subcellular compartmentalization of the enzymes provides a mechanism for the elusive substrate specificity of the different g-secretases and contradicts the dogma that g-secretases indiscriminately cleave many substrates. The more restricted compartmentalization of PSEN2, in contrast to PSEN1, contributes to the intracellular pool of Ab peptide previously associated with the AD disease process (Bayer and Wirths, 2011; Gouras et al., 2010; Pensalfini et al., 2014) . The fact that all FAD-PSEN2 mutations studied here most dramatically increase intracellular Ab42/40 ratios, and the discovery of FAD-PSEN1 mutations that phenocopy FAD-PSEN2 mutations, put our findings also in the context of the understanding of the pathophysiology of AD, stressing the importance of the intracellular generation of aggregation-prone Ab42.
Our work focused mainly on the cellular pathways followed by the PSEN2 complex, which is targeted to LE/LYS via the selective interaction with the AP-1 adaptor complex (Figure 7 ). (E-G) Western blot demonstrating ICD production from endogenous N-cadherin-, APP-, and Notch1-CTFs from membrane fractions of dKO MEFs rescued with GFP-PSEN1, -PSEN2, or -hybrids and -PSEN2 mutants as indicated. (E'-G') Quantification of (E-G) (mean ± SEM; n = 4-5). hyb, hybrid. (H and I) Western blot of intracellular and secreted Ab from total lysate (bottom) and conditioned media (top) (quantified in I; mean ± SEM). (J and K) ELISA of intracellular and extracellular Ab40 and -42, including Ab42/40 (mean ± SEM, n = 7). *p < 0.05; *p < 0.01; ***p < 0.001. See also Figure S4 . PSEN1 complexes that lack the AP-1 interaction motif follow different trafficking routes, frequenting Rab11-positive recycling endosomes, and are more abundant at the cell surface. The molecular basis for this different cell biological behavior between PSEN1 and PSEN2 is provided by a sorting signal, E 16 RTSLM 21 , in the PSEN2 N terminus that had escaped attention until now. Such a motif binds the g1-s1 (AP1G1-AP1S1) hemicomplex of the AP-1 adaptor complex (Mattera et al., 2011) and mediates transport of PSEN2 complexes from the TGN, likely via early endosomal compartments to their final residency in LE/LYS (Figures 3, 4, and 7) . Mutating essential amino acids in this motif abrogates binding to AP-1, as shown by Y3H assays, pull-down experiments, and in silico structural analysis. This same interaction also explains the somatodendritic polarity of PSEN2 in LE/ LYS compartments of primary hippocampal neurons ( Figures  1G and 4C) (Bonifacino, 2014; Farías et al., 2012) . Failure of PSEN2 to bind to AP-1, as evidenced by mutations in the E 16 RTSLM 21 motif, results in a non-polarized distribution of PSEN2 in dendrites and axons ( Figure 4C ).
Two features of this motif emerge from the present study. First, the C-terminal hydrophobic Met determines specificity for AP-1 interaction. Y3H assays demonstrated that mutation of this residue to Leu confers binding to AP-2 but not AP-3, suggesting that yet other structural elements exist that prevent it from interacting with AP-3 ( Figure S2A ). Second, the interaction with AP-1 is abrogated by phosphomimetic mutations of Ser 19 in the E 16 RTSLM 21 motif. We found that Ser 19 behaves as an Aurora A kinase target. Although Aurora A is predominantly known for its role in cell-cycle regulation and mitosis (Nikonova et al., 2013) , this kinase has recently been linked to other functions, such as neurite outgrowth (Takitoh et al., 2012) and mitochondria-associated ER membrane control PSEN1 (yellow) complexes are sorted from the TGN to the cell surface, likely via the Rab11-positive recycling compartments. In contrast, interaction with AP-1 via a conserved ERTSLM motif allows PSEN2 (red) complexes to be sorted to LE/LYS, probably via EEs/sorting endosomes. Phosphorylation of Ser 19 affects PSEN2 sorting. Mutation to Ala confers a more strict localization in LE/LYS and TGN (red dashed arrow). Substituting Ser 19 to Asp (phosphomimetic) decreases binding and results in a more randomized distribution. Changing critical residues in the motif (AxxxAA) fully prevents AP-1 binding, resulting in ''default'' sorting of PSEN2/ g-secretase along the PSEN1/g-secretase transport route (red dashed arrow). LE/LYS localization of PSEN2/g-secretase accounts for a major pool of intracellular Ab, wherein relative Ab42 levels become strongly increased by FAD mutations. (Kashatus et al., 2011) . Moreover, calcium release from the ER, which is affected in AD pathogenesis, might activate Aurora A (Plotnikova et al., 2010) .
The Ser 19 -to-Ala mutation provides the other extreme situation. This mutant shows enhanced binding to AP-1 in co-immunoprecipitation (co-IP) experiments and displays a significant TGN localization different from the localization of WT PSEN2 ( Figures 3G, 3G', and 4D ). This suggests that PSEN2 is dynamically sorted between TGN and LE/LYS and that AP-1 mediates bi-directional transport (Bonifacino, 2014) . The effect of the Ser 19 -to-Ala mutation might then be explained by the enhanced interaction with AP-1, which keeps the PSEN2 mutant associated longer with exit carriers from the TGN and LE/LYS. The apparent correlation of GFP-PSEN2 S 19 A fluorescence with clathrin-coated tubules and vesicles in the TGN, as shown by SIM-CLEM at the ultrastructural level ( Figures 4G and 4G' ), supports this interpretation.
The different mutants and the transplantation experiments of the E 16 RTSLM 21 motif to PSEN1 indicate that this signal is necessary and sufficient to traffic PSEN2 to LE/LYS. Apparently, the other subunits-and, in particular, the variable APH-1 subunit-are not required in this regulation. Other lines of evidence suggest that the APH-1 subunits are responsible for the biochemical differences and/or conformations of the respective g-secretases, with APH-1B favoring the generation of longer Ab peptides (Acx et al., 2014; Serneels et al., 2009 ).
An interesting finding of our study is that localization of the PSEN2/g-secretase plays a major and unanticipated role in the building up of an intracellular Ab pool. Previous work has indicated that intraneuronal Ab progressively accumulates in AD mice models and in the human brain with AD (Gouras et al., 2010) . Since this feature precedes the appearance of tangles and amyloid plaques, the accumulation of intracellular Ab peptide might be a very early event in the pathological cascade leading to AD (Takahashi et al., 2002) . We show here that PSEN2/g-secretase generates the main source of this intracellular pool, which is instigated by its more restricted localization in LE/LYS. Interestingly, intracellular accumulation of Ab is shown to impair proper LE/MVB sorting (Almeida et al., 2006) . Moreover, high local concentrations of Ab in these organelles, together with an acidic pH, has profound effects on the conformation, aggregation, and, probably, toxicity of Ab (Esbjö rner et al., 2014; Hu et al., 2009) , which may be further accelerated by relative increases in more toxic Ab42 (Kuperstein et al., 2010) . PSEN FAD mutations essentially affect the processivity of g-secretase, resulting in the release of longer Ab (Chá vez-Gutié rrez et al., 2012); however, our work here suggests that some mutations in PSEN1 can also shift the subcellular localization to LE/LYS compartments, which is directly correlated with increased intracellular Ab42 at the expense of Ab40 much like mutations in PSEN2. This adds an important and completely unexpected cellular dimension that could potentially impact our understanding of the pathological effects of FAD-PSEN and, in particular, FAD-PSEN2 mutations. Given the strikingly congruent effects of all PSEN2 mutations studied here, we speculate that intracellular Ab toxicity may lead to LE/LYS dysfunction, causing a profound disturbance of proteostasis in the affected cells. It is too early to speculate on the roles that these mechanisms could ultimately also play in other forms of AD. At least several FAD-PSEN1 mutations caused re-localization to LE/LYS compartments, thereby mimicking the FAD-PSEN2 effects, also with respect to substrate processing. It is possible that, in other mutations, the effects on production of Ab dominate the picture, but even there, it is possible that long Ab gets endocytosed and accumulates in the intracellular compartment.
Furthermore, it should be realized that almost all FAD-PSEN1 mutations studied so far result in enzymes that are relatively less efficient in processing than their WT counterparts (Chá vez-Gutié rrez et al., 2012) . This may cause spillover of APP-CTF to the PSEN2 complex, resulting in the production of more Ab in acidic compartments, where Ab is more prone to aggregation (Esbjö rner et al., 2014; Hu et al., 2009 ). Second, it should be noted that early disturbances in endo/lysosomal compartments have been documented as an early characteristic of AD brain (Cataldo et al., 2000; Ginsberg et al., 2010, reviewed in Peric and Annaert, 2015) , and genome-wide association studies (GWASs) have also evidenced the crucial role of the endo/lysosomal sorting system in sporadic AD (Karch and Goate, 2015) . Our work may, indeed, provide an important clue toward the understanding of a crucial pathogenic circle in AD: abnormal processing of APP-CTF (as occurs in FAD) in endo/lysosomes might affect their function; reversibly, subtle alterations in trafficking of APP or in endo/lysosomal biology might deviate Ab generation to these compartments, increasing the pool of intracellular Ab and causing AD in a pernicious feed-forward cycle.
The physiologically most important conclusion from the present work is that sub-compartmentalization of the different g-secretases and their substrates provide specificity as well as spatial and temporal control of their proteolytic activities. Instead of being specific ''proteasomes of the membrane'' (Kopan and Ilagan, 2004) , g-secretases appear to function as intriguingly spatially regulated enzymes with precise functions in different physiological pathways. Additional work in proper cellular and mouse models is needed to further support the potential importance for AD pathogenesis and may provide a rationale for the development of PSEN2/g-secretase specific inhibitors that will act at the heart of intracellular Ab generation.
EXPERIMENTAL PROCEDURES
Additional procedures and details are in the Supplemental Experimental Procedures.
SIM-CLEM
GFP-PSEN2-rescued cells, grown on glass-bottom dishes, co-expressing LAMP1-mCherry or labeled with MitoTracker were fixed, and Z sections were generated by SIM followed by EM processing.
Molecular Modeling
The structure of the AP1 core (PDB: 4P6Z) was used as template for modeling binding with the PSEN2 peptide motif VCDERTSLMS using the FoldX force field (Schymkowitz et al., 2005) . Effects of mutations on interaction energies were analyzed using the BuildModel and Analyze Complex command. Molecular graphics were generated with YASARA (Krieger et al., 2002) .
PSEN1 and PSEN2 KO MNT-1 Cells
The CRISPR Design Tool (http://www.genome-engineering.org/crispr/) was used to select the genomic sequence target in hPSEN1 (5 0 -ggatggac tgcgtggctcat-3 0 ) and hPSEN2 (5 0 -gaccgctatgtctgtagtgg-3 0 ). Oligo pairs encoding 20-nt guide sequences were annealed and ligated into the plasmid pX330 (Addgene). MNT-1 cells were transfected using JetPRIME and KO clones selected by serial dilution.
Isolation of LE/LYS
Cells were incubated (15 min, 37 C) with dimercaptosuccinic acid (DMSA)-coated SPIONs (0.2 mg/ml), washed with PBS, and incubated in fresh medium (4 hr, 37 C). Harvested cells were centrifuged (180 3 g, 10 min), and pellets were resuspended in homogenization buffer (HB; 250 mM sucrose, 5 mM Tris, and 1 mM EGTA [pH 7.4] supplemented with protease inhibitors [PI] ). After cell cracking, a postnuclear supernatant was loaded on an LS column placed in a strong magnetic field (0.5 T, SuperMACSII, Miltenyi Biotec). Nonmagnetic material was removed and after detachment from the magnet, the bound LE/ LYS were eluted, centrifuged (126,000 3 g, 1 hr), and analyzed.
Ab Cells were processed 24 hr after transfection with C99-3xFLAG (or APPsw). Conditioned media were cleared by centrifugation, and cells were lysed in lysis buffer (50 mM Tris-HCL [pH 7.4], 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate). Total Ab was detected by western blot (6E10 antibody). Ab40 and À42 were quantified by ELISA (JRF/cAb40/28 antibody for Ab1-40, JRF/cAb42/26 for Ab1-42, and detection antibody JRF/AbN/25). 
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